Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Hydroquinone

Base Information Edit
  • Chemical Name:Hydroquinone
  • CAS No.:123-31-9
  • Deprecated CAS:57534-13-1,8027-02-9,8027-02-9
  • Molecular Formula:C6H6O2
  • Molecular Weight:110.112
  • Hs Code.:29072210
  • European Community (EC) Number:204-617-8
  • ICSC Number:0166
  • NSC Number:758707,9247
  • UN Number:3077,2662
  • UNII:XV74C1N1AE
  • DSSTox Substance ID:DTXSID7020716
  • Nikkaji Number:J2.929G
  • Wikipedia:Hydroquinone
  • Wikidata:Q419164,Q27102742
  • NCI Thesaurus Code:C29823
  • RXCUI:5509
  • Pharos Ligand ID:8V17FMXBZ9NN
  • Metabolomics Workbench ID:38161
  • ChEMBL ID:CHEMBL537
  • Mol file:123-31-9.mol
Hydroquinone

Synonyms:p-Dihydroxybenzene;Tecquinol;Benzohydroquinone;Benzoquinol;1,4-Dihydrobenzoquinone;1, 4-Dihydroxy-benzol;Idrochinone;1,4-Dihydroxy-benzeen;Diak 5;p-Hydroquinone;NCI-C55834;1, 4-Dihydroxybenzene;Benzene-1,4-diol;p-Dioxybenzene;Derma-Blanch;Hydroquinone (USP);p-Dioxobenzene;Usaf ek-356;1/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8;Tequinol;Hydrochinon (CZECH, POLISH);Quinol;Dihydroquinone;.alpha.-Hydroquinone;1,4-Diidrobenzene;Eldoquin;Eldoquin (TN);1,4-Benzenediol;Hydroquinol;p-Benzenediol;Phiaquin;4-Hydroxyphenol;1,4-Dihydroxybenzen;.beta.-Quinol;Benzene, p-dihydroxy-;Artra;Black and White Bleaching Cream;p-Hydroxyphenol;1,4-Dihydroxybenzene;Eldopaque;Hydroquinole;Tenox HQ;Hidroquinone;Arctuvin;p-dihydroxybenzene, hydroquinone;Hydroquinone,123-31-9;

Suppliers and Price of Hydroquinone
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • Hydroquinone
  • 5g
  • $ 55.00
  • TCI Chemical
  • Hydroquinone >99.0%(T)
  • 25g
  • $ 18.00
  • TCI Chemical
  • Hydroquinone >99.0%(T)
  • 500g
  • $ 36.00
  • Sigma-Aldrich
  • Hydroquinone for synthesis
  • 25 kg
  • $ 866.00
  • Sigma-Aldrich
  • Hydroquinone for synthesis. CAS 123-31-9, EC Number 204-617-8, chemical formula C H (OH) ., for synthesis
  • 8223339025
  • $ 836.00
  • Sigma-Aldrich
  • Hydroquinone United States Pharmacopeia (USP) Reference Standard
  • 500mg
  • $ 366.00
  • Sigma-Aldrich
  • Hydroquinone for synthesis. CAS 123-31-9, EC Number 204-617-8, chemical formula C H (OH) ., for synthesis
  • 8223332501
  • $ 162.00
  • Sigma-Aldrich
  • Hydroquinone for synthesis
  • 2.5 kg
  • $ 155.40
  • Sigma-Aldrich
  • Hydroquinone certified reference material, TraceCERT
  • 100mg
  • $ 96.60
  • Sigma-Aldrich
  • Hydroquinone ReagentPlus , ≥99%
  • 500g
  • $ 81.80
Total 49 raw suppliers
Chemical Property of Hydroquinone Edit
Chemical Property:
  • Appearance/Colour:off-white powder or white needle-like crystals 
  • Vapor Pressure:1 mm Hg ( 132 °C) 
  • Melting Point:172-175 °C(lit.) 
  • Refractive Index:1.689 
  • Boiling Point:286 °C at 760 mmHg 
  • PKA:10.35(at 20℃) 
  • Flash Point:141.6 °C 
  • PSA:40.46000 
  • Density:1.275 g/cm3 
  • LogP:1.09780 
  • Storage Temp.:Refrigerator 
  • Sensitive.:Air & Light Sensitive 
  • Solubility.:H2O: 50 mg/mL, clear 
  • Water Solubility.:70 g/L (20 ºC) 
  • XLogP3:0.6
  • Hydrogen Bond Donor Count:2
  • Hydrogen Bond Acceptor Count:2
  • Rotatable Bond Count:0
  • Exact Mass:110.036779430
  • Heavy Atom Count:8
  • Complexity:54.9
  • Transport DOT Label:Class 9
Purity/Quality:

≥98.1005% *data from raw suppliers

Hydroquinone *data from reagent suppliers

Safty Information:
  • Pictogram(s): HarmfulXn,Dangerous
  • Hazard Codes:Xn,N 
  • Statements: 22-40-41-43-50-68-R68-R50-R43-R41-R40-R22 
  • Safety Statements: 26-36/37/39-61-S61-S36/37/39-S26 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Chemical Classes:Other Classes -> Phenols
  • Canonical SMILES:C1=CC(=CC=C1O)O
  • Recent ClinicalTrials:Prospective Evaluation of Topical Almond Oil vs Hydroquinone
  • Recent EU Clinical Trials:Efficacy and safety of a 4% hydroquinone cream (Melanoderm 4%) for the treatment of melasma: a randomized controlled split-face study.
  • Recent NIPH Clinical Trials:Clinical efficacy of hydroquinone in glaucoma patients with prostaglandin-induced eyelid pigmentation
  • Inhalation Risk:A harmful contamination of the air will not or will only very slowly be reached on evaporation of this substance at 20 °C.
  • Effects of Short Term Exposure:The substance is severely irritating to the eyes. The substance is irritating to the skin and respiratory tract.
  • Effects of Long Term Exposure:Repeated or prolonged contact with skin may cause dermatitis. Repeated or prolonged contact may cause skin sensitization. The substance may have effects on the eyes and skin. This may result in discolouration of the conjunctiva and cornea and skin depigmentation. This substance is possibly carcinogenic to humans.
  • Description Hydroquinone (HQ) is produced by the oxidation of aniline or phenol, by the reduction of quinone, or from a reaction of acetylene and carbon monoxide. Hydroquinone occurs naturally as a glucose ether, also known as arbutin, in the leaves of many plants and in fruits, as well as one of the agents used in the defense mechanism of the bombardier beetle, family Carabidae.
  • Physical properties Colorless to pale brown, odorless, hexagonal crystals
  • Uses Use as photographic reducer and developer; as reagent in the determination of small quantities of phosphate; as antioxidant. Depigmentor hydroquinone is a pigment-lightening agent used in bleaching creams. Hydroquinone combines with oxygen very rapidly and becomes brown when exposed to air. Although it occurs naturally, the synthetic version is the one commonly used in cosmetics. Application to the skin may cause allergic reaction and increase skin sun sensitivity. Hydroquinone is potentially carcinogenic and is associated with causing ochronosis, a discoloration of the skin. The u.S. FDA has banned hydroquinone from oTC cosmetic formulations, but allows 4 percent in prescription products. Its use in cosmetics is prohibited in some european countries and in Australia. K channel agonist, antihypertensive reducing agent prevents polymerization of resin monomers lightens darkened skin, light sensitive Photographic reducer and developer; antioxidant; stabilizing agent for some polymers; intermediate in the manufacturing of some dyes and pigments; in cosmetic formulations.
  • Indications Hydroquinone interferes with the production of the pigment melanin by epidermal melanocytes through at least two mechanisms: it competitively inhibits tyrosinase, one of the principal enzymes responsible for converting tyrosine to melanin, and it selectively damages melanocytes and melanosomes (the organelles within which melanin is stored).
  • Therapeutic Function Depigmentor
  • Clinical Use Hydroquinone is applied topically to treat disorders characterized by excessive melanin in the epidermis, such as melasma. In the United States, nonprescription skin-lightening products contain hydroquinone at concentrations of 2% or less; higher concentrations are available by prescription.
Technology Process of Hydroquinone

There total 706 articles about Hydroquinone which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
With ammonium cerium(IV) nitrate; dihydrogen peroxide; sodium dodecyl-sulfate; In acetic acid; for 48h; Ambient temperature;
DOI:10.1016/S0040-4020(01)85902-0
Guidance literature:
With 3,10-di-n-butylisoalloxazine N-oxide; In acetonitrile; for 6h; Yields of byproduct given; Irradiation;
DOI:10.1039/P19900003339
Guidance literature:
With sodium hydroxide; ozone; at 0 - 20 ℃; Kinetics; Mechanism; Product distribution; dependence from NaOH concn.;
DOI:10.1007/BF00965412
Refernces Edit

Facile and Efficient Carboalkoxylation and Carboaryloxylation of Amines

10.1021/jo01310a057

The research explores the synthesis and reactions of various organic compounds. It includes the preparation of indole derivatives using compounds like 1-methyl-2-vinylpyrrole, methyl propiolate, and hydroquinone, resulting in products such as dimethyl indole-6,7-dicarboxylate and methyl 1-tert-butylindole-7-carboxylate, characterized by melting points, IR spectra, NMR spectra, and elemental analysis. Additionally, the study introduces alkyl and aryl α-methoxyvinyl carbonates (3a-c) as efficient reagents for carboalkoxylation and carboaryloxylation of amines, including weakly basic ones, under mild conditions, yielding high-quality N-carboalkoxylated and N-carboaryloxylated compounds. The research also examines the reactions of [3-(dimethylamino)-2-azaprop-2-en-1-ylidene]dimethylammonium chloride with hydrazines and amidines, producing 1,2,4-triazoles and substituted products, with detailed spectral data confirming the structures of the synthesized compounds.

Synthesis of symmetrical and unsymmetrical subphthalocyanine dimers containing a hydroquinone bridge

10.1142/S1088424613500909

This study focuses on the synthesis and characterization of three novel hydroquinone-based subphthalocyanine (SubPc) dimers. The researchers used phthalonitriles and BCl? to synthesize chloro-subphthalocyanines (Cl-SubPcs), which then underwent axial substitution with hydroquinone to form hydroquinone-substituted SubPcs (Hq-SubPcs). These Hq-SubPcs acted as nucleophiles and reacted with Cl-SubPcs to create symmetrical and unsymmetrical dimers. The synthesis involved reacting hydroquinone and the respective SubPcs in a 1:1 molar ratio in toluene at 180 °C in a pressure vessel. The resulting dimers were characterized using 1H NMR, 13C NMR, UV-vis, fluorescence, and mass spectral analysis. The study highlights the potential of these dimers for applications in optoelectronic devices due to their enhanced solubility and tailored absorption properties.

Dimeric and trimeric molybdenum( II) complexes containing 2-substituted η3-bonded butadienyl bridging ligands

10.1016/s0022-328x(97)00456-7

The study investigates the formation of dimeric and trimeric molybdenum(II) complexes containing 2-substituted 3-bonded butadienyl bridging ligands. The starting material used is [MoCI(CO)2(@-CH2(COCI)C=CH2)phen] (phen = 1,10-phenanthroline) (1). When 1 reacts with 1,2-ethanediol or N,N'-diethylethylenediamine in a 2:1 mole ratio, dimeric complexes [MoCI(CO)2(@-CH/(COACH2)C=CH2)phen]2 are formed, where A represents the substituent group (A = O for ester, A = NEt for amide). Reactions with hydroquinone or 1,4-phenylenediamine yield monomeric complexes [MoCI(CO)2(@-CH2(COA)C=CH2)phen], while dimeric complexes are isolated from reactions involving 4,4'-ethylenedianiline or p-xylylenediamine. Attempts to prepare a novel complex bridged by three linked amide substituted butadienyl groups using diethylenetriamine were unsuccessful. However, reaction of 1 with triethanolamine or tris(2-aminoethyl)amine in a 3:1 mole ratio gives trimeric complexes [MoCI(CO)2(~/a-CH2(COACH2CH2)C=CH2)phen]3 N (A = O, NH) in good yield. The study establishes conditions for the formation of these complexes and examines the boundaries of dimer and trimer formation using various bifunctional and trifunctional reagents.

Iterative synthesis of heterotelechelic oligo(phenylene-vinylene)s by olefin cross-metathesis

10.1021/ol102398y

The study presents an innovative iterative synthesis method for heterotelechelic oligo(phenylene-vinylene)s (OPVs) utilizing olefin cross-metathesis. This approach allows for the creation of oligomers with controlled lengths and paves the way for their assembly into repeating sequence copolymers (RSCs). The process is initiated by a cross-metathesis reaction between olefin-terminated oligomers and a vinylbenzaldehyde, yielding aldehyde-end-capped OPVs. These can then be transformed into metathesis-ready vinyl groups or used for further functionalization, such as the formation of donor-acceptor complexes. The study demonstrates the synthesis of various OPVs with different conjugation lengths, which exhibit tunable optical properties, and also explores the potential for creating complex copolymers through the conversion of OPVs into RSCs. The method's versatility is highlighted by the successful functionalization of OPVs and the potential for applying this metathesis-based coupling to phenylene monomers with a variety of substituents.

Biomimetic synthesis of dimeric metabolite acremine g via a highly regioselective and stereoselective Diels-Alder reaction

10.1021/ol901004e

The study presents a biomimetic synthesis of the dimeric metabolite acremine G, which was achieved through a highly regioselective and stereoselective Diels-Alder reaction between a TBS-protected hydroquinone diene and a structurally related alkenyl quinone. The synthesis involved the use of various chemicals, including toluhydroquinone as the starting material, iodine and silver trifluoroacetate for selective iodination, palladium(II) acetate and triphenylphosphine for the Heck coupling reaction, acetyl chloride and pyridine for dehydration to form the diene, and potassium fluoride, hydrobromic acid, and acetic acid for deprotection steps. These chemicals served the purpose of constructing the necessary precursors and facilitating the key Diels-Alder reaction, which led to the formation of acremine G after a series of transformations and deprotection steps. The study also proposed a mechanism for the oxidation of intermediates to acremine G, suggesting a radical pathway involving electron transfer to molecular oxygen.

Asymmetric Total Synthesis of PD-116740

10.1021/acs.orglett.0c03990

The study presents an asymmetric total synthesis of (+)-PD-116740, an angucyclinone with potent anticancer activity. The synthesis involved a convergent approach with naphthalene-1,5-diol as the starting material, which was converted into quinone derivatives and then reduced to hydroquinone. Selective protection and bromination steps led to the formation of coupling precursors. The D ring fragment was prepared from benzyl alcohol, with TBS protection, lithium/bromide exchange, and conversion to an alkyne. A Pd-catalyzed Suzuki-Miyama coupling reaction combined the A/B and D ring fragments. Asymmetric dihydroxylation using osmium tetroxide and a chiral ligand introduced chirality. The core trans-9,10-dihydrophenanthrene-9,10-diol unit was constructed via oxidative cyclization using Cu(OH)OTf·NMI2 as the oxidant, which also facilitated phenol oxidation. Finally, global deprotection yielded PD-116740.

Post RFQ for Price